Back

Hypo- and hyperthyroidism in patients with new-onset atrial fibrillation: a nationwide study

30 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Drivers and modifiers of atrial fibrillation Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mika Lehto

Helsinki University Hospital, Helsinki (Finland)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor P. Festa (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Doctor P. Haemmerle (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Assistant Professor K. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Doctor T. Watanabe (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Drivers and modifiers of atrial fibrillation

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Amiodarone-induced tyroid dysfunctions: new insights from an observational study
29 June 2021
thumbnail
Congress Presentation
Changes in incidences of clinical outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study since 2010.
27 August 2022
thumbnail
Congress Presentation
Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study
7 April 2024
thumbnail
Congress Presentation
Lymphocytes and monocytes subpopulations in blood of patients with atrial fibrillation or atrial flutter associated with arterial hypertension
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources